A detailed history of Yarbrough Capital, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Yarbrough Capital, LLC holds 7,400 shares of BMY stock, worth $401,968. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,400
Previous 7,400 -0.0%
Holding current value
$401,968
Previous $307,000 24.43%
% of portfolio
0.02%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 01, 2022

BUY
$53.63 - $62.52 $396,862 - $462,648
7,400 New
7,400 $461,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $115B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Yarbrough Capital, LLC Portfolio

Follow Yarbrough Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yarbrough Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yarbrough Capital, LLC with notifications on news.